CS logo
small CS logo
Centre du sein Fribourg

Fribourg, Switzerland
Krebstherapiezentrum in Freiburg

About Centre du sein Fribourg


"Au Centre du sein Fribourg, nous nous engageons à dispenser les meilleurs soins possibles et une prise en charge complète et personnalisée aux personnes atteintes d’un cancer du sein, de l’annonce du diagnostic jusqu’à la fin des soins. Notre centre s’est vu décerné le label de qualité de la Ligue Suisse contre le Cancer en 2017 et la Société suisse de sénologie."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centre du sein Fribourg


During the past decade, Centre du sein Fribourg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centre du sein Fribourg" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Centre du sein Fribourg


According to Clinical.Site data, the most researched conditions in "Centre du sein Fribourg" are "Advanced Breast Cancer" (1 trials) and "Breast Cancer Recurrent" (1 trials). Many other conditions were trialed in "Centre du sein Fribourg" in a lesser frequency.

Clinical Trials Intervention Types at Centre du sein Fribourg


Most popular intervention types in "Centre du sein Fribourg" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alpelisib" (1 trials), "Capecitabine" (1 trials), "Eribulin" (1 trials), "Fulvestrant" (1 trials) and "Palbociclib 125mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centre du sein Fribourg


The vast majority of trials in "Centre du sein Fribourg" are 2 trials for "All" genders.

Clinical Trials Status at Centre du sein Fribourg


Currently, there are NaN active trials in "Centre du sein Fribourg". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centre du sein Fribourg, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre du sein Fribourg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".